GoldenGolden
Frazier Healthcare Partners

Frazier Healthcare Partners

Seattle and Menlo Park-based investment firm with 25 years of history in healthcare investing.

Frazier Healthcare Partners is a Seattle, Washington, United States based venture capital firm founded in 1991.

The firm prefers to invest in companies operating in the pharmaceutical, healthcare services, medical products and biotechnology sectors.

The notable investment portfolio of Frazier Healthcare Partners includes Arcutis Biotherapeutics, Imago BioSciences, Recida Therapeutics, Scout Bio, Sojournix, Tarsus Pharmaceuticals, etc.

As of February 2020, Frazier Healthcare Partners has made 162 investments and had 57 exits.

Frazier Healthcare Partner is a private equity firm in Seattle that prefers to invest in companies focusing on healthcare services, pharmaceutical services, medical products, and related sectors. Founded in 1991 in Seattle, Washington, the firm invests in debt financing. This firm usually invests in Series B, Series C, and Series A rounds. The notable investment portfolio of Frazier Healthcare Partner includes Passage Bio, EBR Systems, Chimerix, CVRx, and Phathom Pharmaceuticals. As of January 2020, Frazier Healthcare Partners has made 355 investments and 160 exits.

Timeline

May 12, 2020
Frazier Healthcare Partners launches Lengo Therapeutics.
1991
Founded

Associated investment funds

People

Name
Role
LinkedIn

Tadataka Yamada

Senior Entrepreneur in Residence

Tadataka Yamada

Venture Partner / Life Sciences Group

Bob Baltera

Entrepreneurs In Residence

Bob Baltera

Entrepreneurs In Residence

Daniel Estes

Partner

Daniel Estes

Partner

Philip Zaorski

Principal

Philip Zaorski

Principal

Shyamal Swami

Associate

Shyamal Swami

Associate

Steve Bailey

CFO

Steve Bailey

CFO

Tadataka Yamada

Venture Partner, Life Sciences Group

Tadataka Yamada

Senior Entrepreneur in Residence

Tracy Saxton

Entrepreneur-In-Residence

Tracy Saxton

Entrepreneur-In-Residence

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

Mirum Pharmaceuticals

Arcutis Biotherapeutics

Arcutis Biotherapeutics

Cirius Therapeutics

Imago BioSciences

Imago BioSciences

Mirum Pharmaceuticals

Passage Bio

Passage Bio

Phathom Pharmaceuticals

Phathom Pharmaceuticals

Recida Therapeutics

Recida Therapeutics

Scout Bio

Scout Bio

Sojournix

Sojournix

Tarsus Pharmaceuticals

News

Title
Author
Date
Publisher
Description
Heather Landi
May 28, 2021
FierceHealthcare
Frazier Healthcare Partners has raised $1.4 billion for its 10th fund to invest in the healthcare sector. Here is where the private equity firm wants to place its bets.
FinSMEs
May 27, 2021
FinSMEs
About | Advertise | Contact | Disclaimer | News | The Daily Deal Newsletter FinSMEs.com by FinSMEs is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.
FinSMEs
May 18, 2021
FinSMEs
About | Advertise | Contact | Disclaimer | News | The Daily Deal Newsletter FinSMEs.com by FinSMEs is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.
Hummingbird Bioscience
May 18, 2021
www.prnewswire.com:443
/PRNewswire/ -- Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets to...
May 12, 2020
BioSpace
Frazier Healthcare Partners Launches Lengo Therapeutics - read this article along with other careers information, tips and advice on BioSpace

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.